Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Staying Ahead of Multiple Autoimmune Disorders Rob Volansky
-
- Six News Items in Psoriatic Arthritis
- Joint Pain and Crohn’s Disease
- European Medicines Agency Reviews Marketing Authorization Application for Adalimumab Biosimilar
- FDA Advisory Committee Unanimously Recommends Approval of Biosimilar to Enbrel
- FDA Advisory Committee Recommends Approval of Biosimilar to Humira
- Comorbid Autoimmunity: Notes From the Field
- The Patient With ANCA-Associated Vasculitis
- Acceptable Tolerability Found With Pirfenidone for SSc-Associated Interstitial Lung Disease
-
- Ipilimumab, Nivolumab Linked With Increased Risk of Autoimmune Joint, Tissue Diseases in Cancer Patients
- Long-Term Follow-up Shows Increased Mortality Risk for Women With RA
- Lupus Impact Tracker Achieved Clinical Validity for Assessment of SLE Patients
- RA Patients on Tofacitinib From High-Risk TB Countries had Greater Chance of TB
- Study Finds Suboptimal Adherence to MTX Treatment in Patients With RA
- Single IV Dose of Dalvance Treats ABSSSI in IDUs Equally Well
- Nasal MRSA Testing Upon Hospital Admission Reduces Clinical Infection
- Solithromycin Noninferior to Moxifloxacin for CABP, Circumvents Macrolide Resistance
-
- VIDEO: Combination Therapies May Improve Response to Checkpoint Inhibitors
- VIDEO: Merge of Immunotherapy, Genomics Lead to Personalized Treatment
- AMA, ACP, Physician Groups Applaud Passage of Opioid Addiction Legislation
- Report: Many Arthritis Patients at Risk for Disability, Reduced Life Expectancy Due to Treatment Delays
- Rheumatology Groups Call for New York Governor to Sign ‘Step Therapy’ Legislation into Law